Related Experiment Video
Updated: Jul 4, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Therapeutic approaches for chronic hepatitis C: a concise review
Allah Nawaz1,2, Azhar Manzoor3, Saeed Ahmed4
1Joslin Diabetes Center, Harvard Medical School, Harvard University, Boston, MA, United States.
This review compares traditional interferon/ribavirin therapy with herbal medicine for Hepatitis C virus (HCV) infection. It explores botanical drugs for preventing and treating HCV, considering viral genetics and patient factors.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection poses a significant global health challenge.
- Effective treatment strategies for HCV are continually evolving.
- Understanding HCV's diverse genome and pathogenesis is crucial for therapeutic advancement.
Purpose of the Study:
- To critically assess current HCV treatment landscapes.
- To compare traditional interferon/ribavirin therapy with herbal medicine approaches.
- To explore the potential of botanical drugs in HCV prevention and treatment.
Main Methods:
- Comprehensive literature review utilizing databases like PubMed, Scopus, and Web of Science.
- Analysis of scientific books and dissertations.
- Focus on HCV genome, variations, pathogenesis, and influencing factors.
Main Results:
- Interferon/ribavirin therapy has been historically significant.
- Herbal medicine represents a complementary and traditional approach.
- Botanical drugs show potential for HCV management.
Conclusions:
- A deep understanding of HCV genetics and influencing factors is key to improving outcomes.
- Herbal medicine warrants further investigation for its role in HCV treatment.
- Integrated approaches may enhance HCV prevention and therapy.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Retrovirus Life Cycles
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...